Company news
Syntara Limited news in 2018
Syntara Limited's news releases, calls and decks from 2018, newest first.
Pharmaxis announces resubmission of bronchitol nda in usa
December 19, 2018
Pharmaxis Announces First Relaunch Sales of Aridol in USA
December 12, 2018
Pharmaxis AGM - CEO Presentation
November 22, 2018
LOX Inhibitor Program for Pancreatic Cancer Phase 1 Ready
November 19, 2018
Pharmaxis Releases Positive Results of Phase 1 Clinical Tria
November 14, 2018
Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor
October 10, 2018
FDA Factory Approval and Relaunch of Aridol in US Market
August 14, 2018
Capital Raising Presentation
August 6, 2018
Trading Halt Announcement - System Upgrade
August 5, 2018
Quarterly Shareholder Update - June 2018
July 26, 2018
LOXL2 Program Attracts Strong Partner Interest at BIO18
June 13, 2018
Quarterly Shareholder Update - March 2018
April 30, 2018
Pharmaxis Earns A$15 Million Milestone Payment
January 10, 2018
New Australian PBS Listing for Brocnhitol
January 1, 2018
Decks in 2018
- Shareholder Meeting (November 2018)
Shareholder meeting · 36 slides · Nov 22, 2018
- Investor Presentation (August 2018)
Investor deck · 28 slides · Aug 6, 2018